The Innovation Space — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

NiKang Therapeuticsnikangtx.comMay 2021

NiKang Therapeutics is a clinical-stage biotechnology company developing small molecule drugs for cancer, using structure-based drug design against targets such as HIF2α, CDK2, KRAS, and SHP2.

BiotechHealthtechWilmington, CN

Yan Lou(Founder)inZhenhai Gao(President, CEO, and Secretary)Hong (Kelsey) Chen(Chief Financial Officer)

BoardGary Yeung(Director)Ting Jia(Director)Roderick Wong(Director)

Co-investorsEcoR1 Capital LAV Lilly Asia Ventures RA Capital Samsara BioCapital Logos

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.